Clinical Management of Chronic Migraine & Headache

Indications for Specialist Neurosurgical Referral

While the majority of headache presentations are primary and benign, clinical vigilance is paramount to differentiate them from secondary pathologies. Identifying specific headache phenotypes and ‘red flag’ symptoms is essential for timely neurosurgical intervention and optimized patient outcomes.

1. Classification of Headache Disorders

Headaches are broadly classified as primary (idiopathic) or secondary (symptomatic of an underlying pathology).

Primary Headache Disorders:

• Tension-type Headache (TTH): Characterized by bilateral, non-pulsatile, “band-like” pressure. It is typically not exacerbated by physical activity.
• Migraine without Aura: Moderate to severe pulsatile pain, usually unilateral, aggravated by exertion, and accompanied by photophobia, phonophobia, and nausea.
• Migraine with Aura: Migraine preceded by focal neurological symptoms—typically visual disturbances, sensory changes, or dysphasia—lasting 20–60 minutes.
• Cluster Headache: Excruciating unilateral periorbital pain, lasting 15–180 minutes, occurring in periodic clusters. Autonomic features include lacrimation, rhinorrhea, and ptosis.

Secondary Headaches arise from intracranial pathologies, including vascular disorders, infections, intracranial pressure (ICP) dysregulation, or space-occupying lesions (tumors).

2. Pathophysiology: The Migraine Brain

Migraine is a complex neurobiological disorder. Current clinical consensus identifies cortical spreading depression (CSD) as the primary trigger for the release of calcitonin gene-related peptide (CGRP). This cascade activates the trigeminovascular system, resulting in neurogenic inflammation and the characteristic pain profile.

The “migraineur” brain exhibits baseline hyperexcitability to external stimuli. While stress acts as a potent trigger, the underlying etiology is fundamentally biological and genetic.

3. Progression to Chronic Migraine

Migraine is classified as chronic when symptoms persist for ≥15 days per month for ≥3 months, with at least 8 days meeting diagnostic criteria for migraine.

Factors driving chronification include:

• Medication Overuse (MOH)
• Unmanaged comorbidities (obesity, sleep apnoea, anxiety, depression)
• High baseline attack frequency

4. Red Flag Symptoms (The SNOOP4 Framework)

Immediate neurosurgical or neurological evaluation is mandatory if a headache presents with:

• S — Systemic symptoms: Fever, unexplained weight loss, or history of malignancy/immunosuppression.
• N — Neurological deficits: Confusion, focal weakness, ataxia, or sudden sensory loss.
• O — Onset: Sudden “thunderclap” onset reaching peak intensity within seconds (suspicion of SAH).
• O — Older age: New-onset headache in patients >50 years.
• P — Positional: Headache exacerbated by recumbency (raised ICP) or standing (low CSF pressure).
• P — Papilloedema: Optic disc swelling on fundoscopy.
• P — Progressive: Steady escalation in frequency or severity.
• P — Pattern change: A significant deviation from a long-standing headache phenotype.

5. Headache and Brain Tumors

While the fear of a brain tumor is prevalent, tumors are a rare cause of isolated headache. In neurosurgical practice, tumor-related headaches are typically associated with raised intracranial pressure. Clinical markers include early-morning headaches, projectile vomiting, new-onset seizures, or progressive focal neurological deficits.

If a headache follows a stable, decades-long migraine pattern without focal deficits, the probability of an underlying structural lesion remains statistically low.

6. Diagnostic Evaluation

• Headache Diary: The cornerstone of diagnostic precision. Documentation of frequency, triggers, and medication response is invaluable.
• Clinical Assessment: Most primary headaches are diagnosed via comprehensive history and detailed neurological examination.
• Neuroimaging (MRI Brain): Indicated for red flags, atypical features, or diagnostic ambiguity. Routine imaging for classic migraine is clinically unnecessary.
• Lumbar Puncture (LP): Reserved for investigating thunderclap headaches (if CT is negative) or suspected idiopathic intracranial hypertension (IIH).

7. Pharmacological Management

Acute (Abortive) Therapy:

• Analgesics: For mild-to-moderate attacks.
• Triptans (e.g., Sumatriptan): Selective 5-HT1B/1D agonists; the gold standard for moderate-to-severe migraine.
• Gepants: CGRP receptor antagonists; an effective alternative for patients with triptan contraindications.

Prophylactic (Preventive) Therapy:

• First-line: Beta-blockers (Propranolol), anticonvulsants (Topiramate), or tricyclics (Amitriptyline).
• Anti-CGRP Monoclonal Antibodies: Specifically engineered for migraine prevention (e.g., Erenumab).
• Botulinum Toxin (Botox): NICE-approved for chronic migraine; follows the PREEMPT protocol (31 injection sites) every 12 weeks.

8. Interventional Neurosurgery & Pain Management

• Greater Occipital Nerve (GON) Block: Infiltration of local anaesthetic and steroid to provide rapid relief and “break” a cycle of chronic pain.
• Sphenopalatine Ganglion (SPG) Block: Effective for cluster headaches and refractory migraine.
• Occipital Nerve Stimulation (ONS): Neuromodulation via implanted electrodes for medically refractory chronic migraine.

9. Evidence-Based Lifestyle Modifications

• Sleep Hygiene: Regularity is paramount. “Let-down” migraines often occur following irregular sleep patterns.
• Caffeine Homeostasis: Avoidance of erratic consumption and withdrawal.
• Hydration: Consistent fluid intake to prevent metabolic triggers.
• Cognitive Behavioural Therapy (CBT): Proven efficacy in reducing the psychological burden of chronic pain.

10. Medication Overuse Headache (MOH)

MOH occurs when the brain becomes sensitized due to excessive use of acute medications.

• Triptans/Opioids: >10 days per month.
• Simple Analgesics: >15 days per month.

Successful management requires the cessation of the offending agent, often necessitating a supervised withdrawal period.

11. Clinical Consultation Checklist

1. Does my headache meet the criteria for chronic migraine?
2. Are there indicators for an MRI brain?
3. Is my current acute medication frequency causing MOH?
4. Which prophylactic strategy offers the best risk-benefit profile?
5. Am I eligible for advanced therapies (Botox or CGRP inhibitors)?

Schedule Your Clinical Assessment

If you are experiencing frequent, debilitating headaches or have noted a change in your symptoms, a specialist neurosurgical review is advised.

Dr Nor Faizal offers comprehensive diagnostic evaluation and advanced interventional options for headache and pain management.

Back to Blog